Uloric
Product Images NDC 21695-516

2 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Uloric (NDC 21695-516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ae1e0d8a 03fc 419b 9d44 Afa68fbd5681 01)

Chemical Structure (Ae1e0d8a 03fc 419b 9d44 Afa68fbd5681 01)
Chemical structure diagram of the active ingredient in ULORIC, showing a molecule with isopropoxy, nitrile, thiazole, methyl, and carboxylic acid groups.*
FDA Label Image

Uloric 80 mg (Ae1e0d8a 03fc 419b 9d44 Afa68fbd5681 02)

Uloric 80 mg (Ae1e0d8a 03fc 419b 9d44 Afa68fbd5681 02)
Label for ULORIC 80mg tablets, 30 count, distributed by Physician Partner, a division of Rebel Distributors Corp. The label states each tablet contains 80mg Febuxostat. Manufacturer is Takeda Pharmaceuticals America, Inc., Deerfield, IL. Includes NDC 21695-516-30 and product ID RU051630. Storage instructions for controlled room temperature and safety warnings are present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.